Results

1–10 of 50 results for intravitreal injection

Short-term Effects of COVID-19-Related Deferral of Intravitreal Injection Visits
William E. Smiddy, MD
Annual Meeting Talks
2021
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoff G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021
Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections
Samir N Patel, MD
Annual Meeting Talks
2021
The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Investigation of Microbial Content of Face Masks Used by Patients Receiving Intravitreal Injections
Avinash V Honasoge, MD, PhD
Annual Meeting Talks
2021
Comparison of Hypochlorous Acid vs. Povidone Iodine Use Prior to Intravitreal Injection: A Randomized Prospective Trial Study
Robert L. Avery, MD
Annual Meeting Talks
2021
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Low Incidence of Endopthalmitis After Intravitreal Injections in an Office Setting Without Gloves and Drapes With a Modified Technique
Kamal Kishore, MD, MBBS
On Demand Cases, Courses, and Papers
2020
A Novel Approach to Endophthalmitis: Administration of Multiple Intravitreal Antibiotic Injections Followed by Delayed Pars Plana Vitrectomy
Ramanath Bhandari, MD
On Demand Cases, Courses, and Papers
2020
Assessment of Online Websites Reliability, Content, and Readability for Intravitreal Injections
Nadim M Rayess, MD
On Demand Cases, Courses, and Papers
2020